Role of ribosomal protein, Rpl22 in regulating leukemic transformation

被引：0
|
作者：
Patel, Nehal Solanki [1 ]
Kushnir, Noa Greenberg [1 ]
Rao, Shuyun [1 ]
Peri, Suraj [1 ]
Rhodes, Michele [1 ]
Nagahawatte, Panduka [2 ]
Mullighan, Charles [2 ]
Wiest, David L. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1269
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Rpl22 is required for IME1 mRNA translation and meiotic induction in S-cerevisiae
    Kim, Stephen J.
    Strich, Randy
    CELL DIVISION, 2016, 11
  • [32] Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint
    Fahl, Shawn P.
    Harris, Bryan
    Coffey, Francis
    Wiest, David L.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (01): : 200 - 209
  • [33] RPL22 Overexpression Promotes Psoriasis-Like Lesion by Inducing Keratinocytes Abnormal Biological Behavior
    Zeng, Jinrong
    Zhang, Yue
    Zhang, Hanyi
    Zhang, Yuezhong
    Gao, Lihua
    Tong, Xiaoliang
    Xie, Yajie
    Hu, Qian
    Chen, Chunli
    Ding, Shu
    Lu, Jianyun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] TRANSFER OF RPL22 TO THE NUCLEUS GREATLY PRECEDED ITS LOSS FROM THE CHLOROPLAST AND INVOLVED THE GAIN OF AN INTRON
    GANTT, JS
    BALDAUF, SL
    CALIE, PJ
    WEEDEN, NF
    PALMER, JD
    EMBO JOURNAL, 1991, 10 (10): : 3073 - 3078
  • [35] RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4
    Weinstein, Hannah N. W.
    Hu, Kevin
    Fish, Lisa
    Chen, Yih-An
    Allegakoen, Paul
    Pham, Julia H.
    Hui, Keliana S. F.
    Chang, Chih-Hao
    Tutar, Meltem
    Benitez-Rivera, Lorena
    Baco, Maria B.
    Song, Hanbing
    Giacomelli, Andrew O.
    Vazquez, Francisca
    Ghandi, Mahmoud
    Goodarzi, Hani
    Huang, Franklin W.
    CELL REPORTS, 2024, 43 (08):
  • [36] Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit
    Cao, Bo
    Fang, Ziling
    Liao, Peng
    Zhou, Xiang
    Xiong, Jianping
    Zeng, Shelya
    Lu, Hua
    ONCOTARGET, 2017, 8 (53) : 90651 - 90661
  • [37] Loss of Ribosomal Protein Paralog Rpl22-like1 Blocks Lymphoid Development without Affecting Protein Synthesis
    Fahl, Shawn P.
    Sertori, Robert
    Zhang, Yong
    Contreras, Alejandra, V
    Harris, Bryan
    Wang, Minshi
    Perrigoue, Jacqueline
    Balachandran, Siddharth
    Kennedy, Brian K.
    Wiest, David L.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (04): : 870 - 880
  • [38] Erratum to: Rpl22 is required for IME1 mRNA translation and meiotic induction in S. cerevisiae
    Stephen K. Kim
    Randy Strich
    Cell Division, 12
  • [39] RPL22 is a tumor suppressor in MSI-high cancers and a key splicing regulator of MDM4
    Weinstein, Hannah N.
    Hu, Kevin
    Fish, Lisa
    Chen, Yih-An
    Allegakoen, Paul
    Hui, Keliana S.
    Pham, Julia H.
    Baco, Maria B.
    Song, Hanbing
    Giacomelli, Andrew O.
    Vazquez, Francisca
    Ghandi, Mahmoud
    Goodarzi, Hani
    Huang, Franklin W.
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Ribosomal protein RPL26 is the principal target of UFMylation
    Walczak, Christopher P.
    Leto, Dara E.
    Zhang, Lichao
    Riepe, Celeste
    Muller, Ryan Y.
    DaRosa, Paul A.
    Ingolia, Nicholas T.
    Elias, Joshua E.
    Kopito, Ron R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (04) : 1299 - 1308
12345